» Articles » PMID: 26244871

CCL18-mediated Down-regulation of MiR98 and MiR27b Promotes Breast Cancer Metastasis

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Aug 6
PMID 26244871
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Our previous work has indicated that CCL18 secreted by tumor-associated macrophages (TAMs) promotes breast cancer metastasis, which is associated with poor patient prognosis. However, it remains unclear whether microRNAs (miRNAs), which may modulate multiple cellular pathways, are involved in the regulation of CCL18 signaling and the ensuing metastasis of breast cancer. In this study, we demonstrated that CCL18 reduces miR98 and miR27b expression via the N-Ras/ERK/PI3K/NFκB/Lin28b signaling pathway, while down-regulation of these mRNAs feedbacks to increase N-Ras and Lin28b levels. This cascade of events forms a positive feedback loop that sustains the activation of CCL18 signaling. More importantly, reduction in miR98 and miR27b enhances the epithelial-mesenchymal transition (EMT) of breast cancer cells, and thus promotes breast cancer metastasis. These findings suggest that down-regulation of miR98 and miR27b promotes CCL18-mediated invasion and migration of breast cancer cells.

Citing Articles

Lin28/let-7 axis in breast cancer.

Shaik Syed Ali P, Ahmad M, Parveen K Mol Biol Rep. 2025; 52(1):311.

PMID: 40085362 DOI: 10.1007/s11033-025-10413-6.


Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors.

Lambrechts Y, Hatse S, Richard F, Boeckx B, Floris G, Desmedt C Cancers (Basel). 2023; 15(17).

PMID: 37686617 PMC: 10486668. DOI: 10.3390/cancers15174341.


Macrophages as a Potential Immunotherapeutic Target in Solid Cancers.

Mishra A, Banday S, Bharadwaj R, Ali A, Rashid R, Kulshreshtha A Vaccines (Basel). 2023; 11(1).

PMID: 36679900 PMC: 9863216. DOI: 10.3390/vaccines11010055.


MicroRNA-Gene Interactions Impacted by Toxic Metal(oid)s during EMT and Carcinogenesis.

Tran F, Lee E, Cuddapah S, Choi B, Dai W Cancers (Basel). 2022; 14(23).

PMID: 36497298 PMC: 9741118. DOI: 10.3390/cancers14235818.


Role of chemokines in the crosstalk between tumor and tumor-associated macrophages.

Qin R, Ren W, Ya G, Wang B, He J, Ren S Clin Exp Med. 2022; 23(5):1359-1373.

PMID: 36173487 PMC: 10460746. DOI: 10.1007/s10238-022-00888-z.


References
1.
Mantovani A, Allavena P, Sica A, Balkwill F . Cancer-related inflammation. Nature. 2008; 454(7203):436-44. DOI: 10.1038/nature07205. View

2.
Jin T, Xu X, Hereld D . Chemotaxis, chemokine receptors and human disease. Cytokine. 2008; 44(1):1-8. PMC: 2613022. DOI: 10.1016/j.cyto.2008.06.017. View

3.
Roush S, Slack F . The let-7 family of microRNAs. Trends Cell Biol. 2008; 18(10):505-16. DOI: 10.1016/j.tcb.2008.07.007. View

4.
Hitchler M, Domann F . Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radic Biol Med. 2009; 47(2):115-27. PMC: 2728018. DOI: 10.1016/j.freeradbiomed.2009.04.010. View

5.
DeNardo D, Barreto J, Andreu P, Vasquez L, Tawfik D, Kolhatkar N . CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 2009; 16(2):91-102. PMC: 2778576. DOI: 10.1016/j.ccr.2009.06.018. View